D-Wave, Quantums

D-Wave Quantum's $33.4 Million Backlog Cannot Mask the Revenue Gap—Now Management Must Sell the Vision

18.05.2026 - 20:41:28 | boerse-global.de

D-Wave Quantum shares slide 8% despite record $33.4M bookings; revenue plunges 81% to $2.9M. Investor day and roadshows aim to address dilution and revenue conversion concerns.

D-Wave Quantum's $33.4 Million Backlog Cannot Mask the Revenue Gap—Now Management Must Sell the Vision - Foto: über boerse-global.de
D-Wave Quantum's $33.4 Million Backlog Cannot Mask the Revenue Gap—Now Management Must Sell the Vision - Foto: über boerse-global.de

D-Wave Quantum enters a critical stretch this month, with three Wall Street roadshow appearances and its first-ever investor day looming. The stock, which slid 8.26% on Monday to €16.04 in European trading, has now given back 21.33% over the past week. The message from the market is clear: record orders do not automatically translate into dependable revenue.

The company’s first-quarter numbers lay bare the tension. Revenue collapsed 81% to $2.9 million (some reports put the figure at $2.86 million), missing the consensus forecast of $4.14 million (or $4.19 million, depending on the source). The culprit was the absence of high-margin system sales that had buoyed the prior-year period. On the bottom line, however, D-Wave beat expectations, posting a net loss of $0.05 per share against the $0.08 loss analysts had penciled in.

The real story lies in the order book. Bookings hit a record $33.4 million in the first quarter, compared with just $1.6 million a year earlier—a staggering 1,994% leap. Remaining performance obligations stood at $42.4 million. That kind of momentum would normally send a stock higher, but investors are demanding proof that these orders will convert into predictable, recurring income rather than episodic spikes.

D-Wave’s balance sheet offers some cushion. After acquiring Quantum Circuits Inc., the company held $588.4 million in cash and marketable securities as of March 31, up 93% year-over-year. The acquisition added fault-tolerant superconducting gate-model technology to D-Wave’s annealing expertise, creating an unusual dual-platform offering. Strategically, that broadens the addressable market, but it also adds complexity to the execution story.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The share count remains the most sensitive issue. D-Wave recently corrected its quarterly filing to show 367,269,074 common shares outstanding instead of the previously reported 366,737,601—a minor technical adjustment that touches a raw nerve. The number of shares has swelled by roughly 67% over the past twelve months, and a $330 million shelf registration gives the company ample latitude to raise more capital. The QCI acquisition alone included a $300 million stock component, forcing existing shareholders to weigh growth against dilution.

Management has a packed calendar to address these doubts. The roadshow kicks off May 20 at J.P. Morgan’s technology conference in Boston, followed by Canaccord Genuity on May 21 and TD Cowen on May 28 in New York. The pace is deliberate: the narrative needs to sharpen after the mixed quarterly report. On June 1, D-Wave will host its first investor day at the New York Stock Exchange, where executives plan to walk through technology, sales strategy, QCI integration, and financial planning.

Key contracts provide talking points but also highlight concentration risk. The Florida Atlantic University deal, worth $20 million, includes training and the installation of an Advantage2 system before year-end. A Fortune 100 company signed a $10 million quantum-computing-as-a-service contract. Both are significant wins, yet large individual transactions can swing bookings unpredictably. To build a higher-quality revenue stream, D-Wave needs repeatable demand from cloud-based quantum services.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

The company has raised its delivery target to at least two annealing systems in 2026, up from one previously. That step-up must be backed by concrete revenue. Benchmark and Wedbush each maintain a $35 price target, betting that commercial applications and progress toward logical quantum computing will eventually validate the valuation. But with the stock down 28.15% year-to-date, patience is wearing thin.

The investor day will be followed by Qubits Europe in London on June 18, where D-Wave plans to showcase a quantum-classical blockchain testnet developed with Postquant Labs. Each event is a chance to demonstrate that the order pipeline is not just a collection of large one-offs, but a foundation for sustainable growth. For now, the market is waiting to see whether the story adds up.

Ad

D-Wave Quantum Stock: New Analysis - 18 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

So schätzen die Börsenprofis D-Wave Aktien ein!

<b>So schätzen die Börsenprofis D-Wave Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US26740W1099 | D-WAVE | boerse | 69367654 |